CNS Pharmaceuticals Inc. (CNSP)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.10

3.41%

After-hours Dec 13, 2024, 06:43 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	-	-	-	-	-	-	-
Cost of Revenue	4.13K	11.76K	13.07K	11.10K	1.96K	-	-
Gross Profit	-4.13K	-11.76K	-13.07K	-11.10K	-1.96K	-	-
Operating Income	-18.87M	-15.27M	-14.03M	-9.45M	-3.83M	-881.79K	-215.10K
Interest Income	13.88K	7.03	9.29	3.26	44.23	-	10.22K
Pretax Income	-18.85M	-15.27M	-14.04M	-9.46M	-3.88M	-7.39M	-219.36K
Net Income	-18.85M	-15.27M	-14.50M	-9.46M	-3.88M	-7.39M	-526.47K
Selling & General & Admin	4.77M	5.97M	4.68M	4.39M	1.98M	860.52K	182.47K
Research & Development	14.10M	9.30M	9.35M	5.06M	1.85M	21.27K	32.64K
Other Expenses	-	-	-	-	-	-6.46M	-
Operating Expenses	18.87M	15.27M	14.03M	9.45M	3.83M	881.79K	215.10K
Interest Expense	-	7.03K	9.29K	3.26K	44.23K	46.70K	-
Selling & Marketing Expenses	-	-	-	-	-	-	-255.45K
Cost & Expenses	18.87M	15.27M	14.03M	9.45M	3.83M	881.79K	215.10K
Income Tax	-	7.03K	9.29K	3.26K	42.28K	46.70K	-516.25K
Shares Outstanding (Basic)	75.00K	27.23M	17.00M	11.00M	10.97M	10.97M	10.97M
Shares Outstanding (Diluted)	75.35K	27.23M	17.57M	11.08M	10.97M	10.97M	10.97M
EPS (Basic)	-251.35	-560.83	-852.66	-859.81	-353.57	-674.07	-48.01
EPS (Diluted)	-250.19	-560.83	-825.04	-853.68	-353.57	-674.07	-48.01
EBITDA	-18.86M	-15.26M	-14.47M	-9.44M	-3.83M	-6.46M	-
Depreciation & Amortization	4.13K	11.76K	13.07K	11.10K	1.96K	881.79K	516.25K